Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcoma
- 12 April 2016
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Imaging Pediatric Bone SarcomasRadiologic Clinics of North America, 2011
- Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective studyActa Oncologica, 2011
- The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)Cancer, 2009
- Ewing sarcoma demonstrates racial disparities in incidence‐related and sex‐related differences in outcomeCancer, 2009
- Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the futureCurrent Opinion in Oncology, 2008
- Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumoursNuclear Medicine Communications, 2006
- [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of TumorsJournal of Clinical Oncology, 2005
- Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviewsJournal of Clinical Epidemiology, 2005
- Molecular imaging of cancer with positron emission tomographyNature Reviews Cancer, 2002